{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:13:24Z","timestamp":1781090004529,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jvs.2025.03.057","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:16:26Z","timestamp":1741781786000},"page":"559-568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of statin therapy in patients treated with drug-eluting and drug-coated stents for femoropopliteal lesions"],"prefix":"10.1016","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-473X","authenticated-orcid":false,"given":"Tatsuro","family":"Takei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yanagiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yanagiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2025.03.057_bib1","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00270-021-02901-6","article-title":"24-month efficacy and safety results from Japanese patients in the IMPERIAL randomized study of the Eluvia drug-eluting stent and the Zilver PTX drug-coated stent","volume":"44","author":"Iida","year":"2021","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.jvs.2025.03.057_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00270-020-02693-1","article-title":"Two-year efficacy and safety results from the IMPERIAL randomized study of the Eluvia polymer-coated drug-eluting stent and the Zilver PTX polymer-free drug-coated stent","volume":"44","author":"M\u00fcller-H\u00fclsbeck","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2025.03.057_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/15266028231179861","article-title":"One year outcomes of Zilver PTX versus Eluvia for femoropopliteal disease in real-world practice: REALDES study","volume":"32","author":"Shibata","year":"2025","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.03.057_bib4","article-title":"Comparing predictors influencing restenosis following high-dose drug-coated balloon angioplasty and fluoropolymer-based drug-eluting stenting in femoropopliteal artery lesions","author":"Kurata","year":"2023","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jvs.2025.03.057_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5551\/jat.50369","article-title":"One-year late lumen loss between a polymer-coated paclitaxel-eluting stent (Eluvia) and a polymer-free paclitaxel-coated stent (Zilver PTX) for femoropopliteal disease","volume":"27","author":"Soga","year":"2020","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jvs.2025.03.057_bib6","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jvir.2016.05.037","article-title":"The influence of statin therapy on restenosis in patients who underwent nitinol stent implantation for de novo femoropopliteal artery disease: two-year follow-up at a single center","volume":"27","author":"Kim","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2025.03.057_bib7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jvs.2017.09.022","article-title":"The Association of Statin Therapy with the primary patency of femoral and popliteal artery stents","volume":"67","author":"de Grijs","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.057_bib8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jvs.2014.02.012","article-title":"Endovascular treatment of lesions in the below-knee popliteal artery","volume":"60","author":"Siracuse","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.057_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jvs.2011.08.044","article-title":"Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia","volume":"55","author":"Aiello","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.057_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11096-022-01513-5","article-title":"Effects of statin use on primary patency, mortality, and limb loss in patients undergoing lower-limb arterial angioplasty: a systematic review and meta-analysis","volume":"45","author":"Braun","year":"2023","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jvs.2025.03.057_bib11","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2025.03.057_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1253\/circj.CJ-22-0650","article-title":"Prevalence and effects of high-intensity statins for Japanese patients presenting with acute coronary syndrome - a post hoc secondary analysis of STOPDAPT-2 ACS","volume":"87","author":"Watanabe","year":"2023","journal-title":"Circ J"},{"key":"10.1016\/j.jvs.2025.03.057_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0140-6736(92)90863-X","article-title":"Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas\u2019 Atherosclerosis Regression Study (STARS)","volume":"339","author":"Watts","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2025.03.057_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0002-9149(99)00910-8","article-title":"Effect of statin therapy on restenosis after coronary stent implantation","volume":"85","author":"Watts","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jvs.2025.03.057_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jtcvs.2006.12.064","article-title":"The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery","volume":"134","author":"Momin","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2025.03.057_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1568006013338187","article-title":"Pleiotropic effects of statins on the vascular tissue","volume":"1","author":"Ikeda","year":"2001","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"10.1016\/j.jvs.2025.03.057_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jcin.2022.01.019","article-title":"1-year outcomes of fluoropolymer-based drug-eluting stent in femoropopliteal practice: predictors of restenosis and aneurysmal degeneration","volume":"15","author":"Iida","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.03.057_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jcin.2015.03.022","article-title":"1-year results of the Zephyr Registry (Zilver PTX for the femoral artery and proximal popliteal artery): predictors of restenosis","volume":"8","author":"Iida","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.03.057_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2011.09.036","article-title":"Classification and clinical impact of restenosis after femoropopliteal stenting","volume":"59","author":"Tosaka","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.03.057_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12928-016-0411-3","article-title":"Potential mechanisms of in-stent occlusion in the femoropopliteal artery: an angioscopic assessment","volume":"32","author":"Ishihara","year":"2017","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.jvs.2025.03.057_bib21","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jvs.2016.08.094","article-title":"Statin use in patients with peripheral arterial disease","volume":"64","author":"Harris","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.057_bib22","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/eurheartj\/ehae207","article-title":"Lower extremity arterial disease vs. coronary artery disease: mortality differences after revascularization","volume":"45","author":"Takahara","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2025.03.057_bib23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.5551\/jat.62892","article-title":"Ambulatory status over time after revascularization in patients with chronic limb-threatening ischemia","volume":"29","author":"Kodama","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jvs.2025.03.057_bib24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2011.09.067","article-title":"Meta-analysis of statin effects in women versus men","volume":"59","author":"Kostis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2025.03.057_bib25","first-page":"422","article-title":"Comparative 2-year outcomes of the Misago stent versus other self-expandable nitinol stents for the endovascular treatment of aortoiliac disease","volume":"64","author":"Haraguchi","year":"2023","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jvs.2025.03.057_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jvs.2003.08.030","article-title":"Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality","volume":"39","author":"Henke","year":"2004","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.057_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jvs.2016.02.059","article-title":"Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction","volume":"64","author":"Klingelhoefer","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2025.03.057_bib28","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.jcin.2023.08.022","article-title":"Low-dose vs high-dose drug-coated balloon for symptomatic femoropopliteal artery disease: the PROSPECT MONSTER study outcomes","volume":"16","author":"Nakama","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2025.03.057_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025677","article-title":"Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion","volume":"12","author":"Soga","year":"2023","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521425004434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521425004434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T18:34:50Z","timestamp":1754073290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521425004434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0741521425004434"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2025.03.057","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of statin therapy in patients treated with drug-eluting and drug-coated stents for femoropopliteal lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2025.03.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Society for Vascular Surgery. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}